Tolerability of NT-301 Nasal Spray

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Tolerability of NT-301 Nasal Spray trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT06954428

Clinical Trial of Intranasal Delivery of NT-301

The purpose of this research project is to investigate the safety and tolerability of an approved drug (Apomorphine) when administered as a nasal powder spray f…

Australia49 participantsStarted 2025-06-20

Treatment: NT-301 1 mg, NT-301 2 mg